NORTHBROOK, Ill., and Aspen, Colorado, April 2, 2015 /3BL Media/ - Astellas Pharma US, Inc., in partnership with the Chris Klug Foundation (CKF), is pleased to sponsor the second annual Bounce Back Award. Nominations are now being accepted for the award, which will recognize two transplant recipients who exhibit a great post-transplant quality of life, whether it is a career accomplishment, participation in a sport or hobby, or simply leading a fulfilling life with family and loved ones.
Molly Fletcher – nicknamed “the female Jerry Maguire” by CNN – presented five keys to changing your life during her keynote speech at the 2015 Northern Trust Open. Fletcher inspired more than 160 female business leaders from the Los Angeles area at the PGA TOUR Executive Women’s Day sponsored by Astellas Pharma US, Inc.
NORTHBROOK, Ill., March 25, 2015 /3BL Media/ – Astellas, a leading pharmaceutical company based in Northbrook, Ill., has been named one of America’s Best Employers in the biotechnology industry by Forbes Magazine. The list is a first of its kind for Forbes, based on a survey of over 20,000 anonymous respondents from across the country.
Northbrook, IL, March 25, 2015 /3BL Media/ – Astellas has become a national corporate partner of The Trevor Project to help advance the shared mission of ending suicide among gay, lesbian, bisexual, transgender and questioning (LGBTQ) young adults. According to the Centers for Disease Control, LGBTQ youth are three to four times more likely to attempt suicide as their straight peers.
Astellas presents Executive Women's Day at The Honda Classic was an engaging daylong event focused on professional development, networking, health and wellness. The PGA TOUR and Astellas will support 23 Executive Women’s Day events in cities across the country this year.
TOKYO, Feb. 2, 2015 /3BL Media/ - Astellas Pharma Inc. (Tokyo: 4503, “Astellas”) announced today that the company will now make trial data available through www.clinicalstudydatarequest.com, an independent Web site that enables researchers to request and access clinical trial data after approval of a research proposal by an independent review panel.
Astellas to Present at J.P. Morgan Healthcare Conference
Multimedia with summary
The top players in the pharmaceutical industry are heading to the 33rd Annual J.P. Morgan Healthcare Conference this week to revisit the many successes of 2014, and to better understand what challenges and opportunities the industry will face in 2015. Although budgets are shrinking, the changing healthcare landscape presents many opportunities to further develop innovative medicines for patients.
December 9, 2014 /3BL Media/ - Astellas Pharma Inc. (TSE: 4503; Headquarters: Tokyo; President & CEO: Yoshihiko Hatanaka) announced that it has been selected for the third year to be included in the FTSE4Good Index, one of the world’s premier indexes for socially responsible investment.
Company Receives Perfect Score on Human Rights Campaign’s Corporate Equality Index
NORTHBROOK, Ill., Nov. 19, 2014 /3BL Media/ – Astellas, a leading pharmaceutical company, received a perfect score on the Human Rights Campaign’s (HRC) annual Corporate Equality Index (CEI). The CEI is a national benchmarking tool used to rate companies on policies and practices concerning lesbian, gay, bisexual and transgender (LGBT) employee equality.